These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37052145)

  • 21. Biological intersection of sex, age, and environment in the corticotropin releasing factor (CRF) system and alcohol.
    Agoglia AE; Crofton EJ; Herman MA
    Neuropharmacology; 2020 Jun; 170():108045. PubMed ID: 32217364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational approaches to medication development.
    Bartlett S; Heilig M
    Curr Top Behav Neurosci; 2013; 13():543-82. PubMed ID: 21590390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
    Bruchas MR; Land BB; Chavkin C
    Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.
    Heilig M; Thorsell A; Sommer WH; Hansson AC; Ramchandani VA; George DT; Hommer D; Barr CS
    Neurosci Biobehav Rev; 2010 Nov; 35(2):334-44. PubMed ID: 19941895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced transgenic approaches to understand alcohol-related phenotypes in animals.
    Bilbao A
    Curr Top Behav Neurosci; 2013; 13():271-311. PubMed ID: 22389179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging pharmacotherapies for alcohol use disorder.
    Mason BJ
    Neuropharmacology; 2017 Aug; 122():244-253. PubMed ID: 28454983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
    Martin-Fardon R; Zorrilla EP; Ciccocioppo R; Weiss F
    Brain Res; 2010 Feb; 1314():145-61. PubMed ID: 20026088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dark side of emotion: the addiction perspective.
    Koob GF
    Eur J Pharmacol; 2015 Apr; 753():73-87. PubMed ID: 25583178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting opioid and neurokinin-1 receptors to treat alcoholism.
    Rodriguez FD; Coveñas R
    Curr Med Chem; 2011; 18(28):4321-34. PubMed ID: 21861818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.
    Schreiber AL; Gilpin NW
    Handb Exp Pharmacol; 2018; 248():435-471. PubMed ID: 29374836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence.
    Kaye JT; Bradford DE; Magruder KP; Curtin JJ
    J Stud Alcohol Drugs; 2017 May; 78(3):353-371. PubMed ID: 28499100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system mechanisms in alcohol relapse.
    McBride WJ; Le AD; Noronha A
    Alcohol Clin Exp Res; 2002 Feb; 26(2):280-6. PubMed ID: 11964569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
    Logrip ML; Koob GF; Zorrilla EP
    CNS Drugs; 2011 Apr; 25(4):271-87. PubMed ID: 21425881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocircuitry targets in ethanol reward and dependence.
    Koob GF; Roberts AJ; Schulteis G; Parsons LH; Heyser CJ; Hyytiä P; Merlo-Pich E; Weiss F
    Alcohol Clin Exp Res; 1998 Feb; 22(1):3-9. PubMed ID: 9514280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of Nociceptin/Orphanin FQ and Dynorphin Systems in the Extended Amygdala of Alcohol Preferring Marchigian Sardinian (msP) Rats.
    Caputi FF; Stopponi S; Rullo L; Palmisano M; Ubaldi M; Candeletti S; Ciccocioppo R; Romualdi P
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rats on the grog: novel pharmacotherapies for alcohol craving.
    McGregor IS; Gallate JE
    Addict Behav; 2004 Sep; 29(7):1341-57. PubMed ID: 15345269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.
    Phillips TJ; Reed C; Pastor R
    Genes Brain Behav; 2015 Jan; 14(1):98-135. PubMed ID: 25565358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurobiology of alcohol seeking behavior.
    Domi E; Domi A; Adermark L; Heilig M; Augier E
    J Neurochem; 2021 Jun; 157(5):1585-1614. PubMed ID: 33704789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism.
    Gehlert DR; Cippitelli A; Thorsell A; Lê AD; Hipskind PA; Hamdouchi C; Lu J; Hembre EJ; Cramer J; Song M; McKinzie D; Morin M; Ciccocioppo R; Heilig M
    J Neurosci; 2007 Mar; 27(10):2718-26. PubMed ID: 17344409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous opioid systems and alcohol addiction.
    Herz A
    Psychopharmacology (Berl); 1997 Jan; 129(2):99-111. PubMed ID: 9040115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.